Metric Finance
LearnFAQ
LearnFAQ

Learn / HAE

NYSE: HAE

Haemonetics (HAE) stock, explained like you're 5

Haemonetics trades on the New York Stock Exchange under the ticker HAE. It is a mid cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 5.4 billion dollars.

Ticker
HAE
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Medical/Dental Instruments
Size
Mid cap, about 5.4 billion dollars

Is Haemonetics a small, medium or large cap company?

No. Haemonetics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.4 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Haemonetics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves HAE stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • HAE Jan 2027 75.000 put (HAE270115P00075000) interactive stock chart (Yahoo Finance UK)
  • Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now? (TradingView)
  • Haemonetics reports USD 339.38 million revenue: Haemonetics stock has 57.98 times earnings (ad-hoc-news.de)
  • Haemonetics Stock Surges as Plasma Deal Opens Door to More Revenue (Barron's)
  • Haemonetics Gains 149.3% in a Year: What's Driving the Rally? (Yahoo Finance)

Follow HAE in your daily brief

Each trading day at 5 PM ET we post what happened to Haemonetics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow HAE

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Haemonetics stock

What does Haemonetics do?

Haemonetics trades on the New York Stock Exchange under the ticker HAE. It is a mid cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 5.4 billion dollars.

What is the ticker symbol for Haemonetics?

Haemonetics trades under the ticker HAE on the New York Stock Exchange.

What is Haemonetics's market cap?

Haemonetics is a mid cap stock with a market cap of about 5.4 billion dollars.

How does Haemonetics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves HAE stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow HAE stock every day?

Add HAE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow HAE daily

A free brief on Haemonetics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • SYK · Stryker
  • BDX · Becton Dickinson & co
  • MDLN · Medline
  • RMD · Resmed

Similar stocks

  • SYKStryker
  • BDXBecton Dickinson & co
  • MDLNMedline
  • RMDResmed

Compare HAE: HAE vs SYK, HAE vs BDX, HAE vs MDLN

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed